Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gates Foundation Challenges World's Scientists

By Biotechdaily staff writers
Posted on 12 Feb 2003
The Bill and Melinda Gates Foundation has announced a research program for improving the health of people in developing countries. More...
The first phase will seek to identify the leading causes of death in poorer countries, to be followed by an international US$200 million competition designed to entice scientists to find ways to prevent those causes of death. The program was announced at the meeting of the World Economic Forum in Davos (Switzerland) by Mr. Gates, who is the founder of Microsoft. He emphasized that health problems are preventing economic growth in poorer countries.

Around four billion people live in developing countries, representing two-thirds of the world's population, yet only 10% of all medical research is dedicated to diseases such as malaria, tuberculosis, malnutrition and other conditions causing 90% of worldwide health problems. Instead, most researchers are focusing on "rich world” diseases, according to Mr. Gates.

An international panel of scientists will decide on specific challenges in global health that would lead to improved well being and fewer deaths. Dr. Harold Varmus, president of Memorial Sloan-Kettering Cancer Center (New York, NY) and formerly a director of the US National Institutes of Health, has been appointed chairman of the panel. During the summer of 2003, the panel will publish a list of priorities. Among the challenges being considered are: finding new approaches to protect children from diarrhea and respiratory infections, finding new approaches to prevent and treat patients with AIDS, and finding a way to block the reactivation of tuberculosis.

Following this phase, grants of up to US$20 million each will be awarded over the next three to five years. These will probably be awarded to coalitions of scientists from different institutions and disciplines and also to some individual scientists. The grants are to be administered by the Foundation for the National Institutes of Health (Bethesda, MD, USA). Mr. Gates said the program was inspired by a German mathematician, David Hilbert, who challenged other mathematicians in 1900 to solve 23 problems. This resulted in mathematic breakthroughs and other advances, including the development of computers.





Related Links:
Memorial Sloan-Kettering
Foundation for the National Institutes of Health

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.